Ophthalmology Times - Ophthalmology news, articles, and events
网页EyeCon 2024: Key takeaways for enhanced patient care from Day 1. This Week in Ophthalmology: Week of September 22, 2024. EyeCon 2024: Peter McDonnell, MD, and Laura Periman, MD, on the importance of integrating new knowledge into practice. Eyecon 2024: Thyroid Eye Disease in focus. Retina Society 2024: A comparison of tyrosine …
Physicians sort out pros and cons of several new IOLs on the market
网页2021年11月12日 · The new IOL in the EDoF category is the AcrySof IQ Vivity (Alcon). The Vivity uses wavefront-shaping technology on its anterior surface that elongates the depth of focus, giving about a 1.5 D range of vision. Because it is a nondiffractive lens, risks of glare and halos are minimized and quality of vision is better than with a multifocal IOL.
Breaking down the dorzolamide shortage - Ophthalmology Times
网页2019年8月9日 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in a …
IPL + thermal pulsation: A thorough approach to dry eye
网页2018年11月6日 · This one-two punch approach is logical: IPL treats inflammation, the underlying cause of dry eye disease. Thermal pulsation addresses meibomian gland dysfunction (MGD), a major component of dry eye pathology, by unclogging the glands and evacuating their abnormal content. When we treat both the inflammatory source and the …
Identifying, managing dysphotopsia after cataract surgery
网页2014年4月25日 · Boston — Following cataract surgery, patients can present with a variety of visual complaints-i.e., dysphotopsias, aberrant optical phenomena that interfere with vision after IOL implantation. Positive dysphotopsias include rainbows, streaks, crescents, rings, halos, and veiling glare, haze, and fog. Negative dysphotopsias are relative and ...
Myths and misconceptions about autologous serum for dry eye
网页2020年6月22日 · Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more …
FDA approves eye drops for treatment of presbyopia
网页2021年10月30日 · Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia. Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. According to …
Thea receives FDA approval for preservative-free latanoprost for …
网页2022年12月16日 · The FDA has approved latanoprost ophthalmic solution 0.005% (IYUZEH, Thea Pharma Inc.) for decreasing elevated intraocular pressure in open-angle glaucoma and ocular hypertension. The agent is the first and only clinically proven preservative-free drop formulation of latanoprost currently available in the US, according to the company.
FDA-approved eye drops target presbyopia patients
网页2021年11月14日 · Allergan, a subsidiary of AbbVie, announced on October 29, 2021, that the US Food and Drug Administration (FDA) has approved pilocarpine HCl Ophthalmic Solution 1.25% for the treatment of adult patients with presbyopia. Pilocarpine HCl ophthalmic solution 1.25% is the first and only approved eye drop to treat age-related …
Combination eye drop manages inflammation and infection after …
网页2022年4月23日 · Blake K. Williamson, MD, MPH, MS, and coauthor Urvi Patel, BSc, presented an e-poster at the American Society of Cataract and Refractive Surgery’s 2022 annual meeting in Washington, D.C., on the efficacy of a combination eye drop comprised of an antibiotic, anti-inflammatory and lubricant as part of a postoperative treatment …